LATITUDE: A phase III, double-blind, randomized trial of androgen deprivation therapy with abiraterone acetate plus prednisone or placebos in newly diagnosed high-risk metastatic hormone-naive prostate cancer
Yazar
Park, Youn C.
Ozguroglu, Mustafa
Kheoh, Thian
Todd, Mary Beth
Chi, Kim N.
Fizazi, Karim
Tran, Namphuong
Fein, Luis Enrique
Matsubara, Nobuaki
Antolin, Alfredo Rodriguez
Alekseev, Boris Y.
Ye, Dingwei
Feyerabend, Susan
Protheroe, Andrew
De Porre, Peter
Üst veri
Tüm öğe kaydını gösterBağlantı
http://hdl.handle.net/20.500.12627/110087https://doi.org/10.1200/jco.2017.35.15_suppl.lba3
Koleksiyonlar
- Bildiri [64839]